Loading
MC
Mountain Crest Acquisition Corp. III Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Mountain Crest Holdings III LLC, was filed 16 Jun 2021.
Mountain Crest Acquisition Corp. III: what insiders have been doing
Every trade that managers of Mountain Crest Acquisition Corp. III disclose to SEC (Form 4) is tracked on this page. The company sits in the Healthcare & Pharma sector. No insider at Mountain Crest Acquisition Corp. III has published a filing in the past twelve months. The most recent one dates from 22 February 2023.
Over the whole record (from 2021), the tally stands at 2 purchases and 2 sales.
In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
8
Thresholds
n/a
Buy Volume
€916,975
2 ops. · all time
Sell Volume
€2M
2 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended January 2026 · cache
US$10.05
Analyst consensus
Valuation
P/Book1.5x
Balance sheet & cash
Market capUS$87M
Debt / Equity1%
Profitability & ownership
% insiders36.6%
% institutions41.5%
Last declaration on 22 February 2023
Declarations8 total
522,165 shares@ US$10.3199.5% of flowCommon Stock, par value $0.0001 per shareSEC:0000902664-23-001976:0
2,835 shares@ US$10.400.5% of flowCommon Stock, par value $0.0001 per shareSEC:0000902664-23-001235:0
200,000 shares@ US$12.5070.8% of flowCommon StockSEC:0001104659-22-009712:0
▼
Same trade as the filing by Mountain Crest Holdings III LLC, counted once · View ↗
200,000 shares@ US$12.5070.8% of flowCommon StockSEC:0001104659-22-009714:0
2,086 shares@ US$10.000.5% of flowCommon StockSEC:0001104659-21-082212:0
Canonical exit: 12 Sept 2021 (T+90)
▲
Same trade as the filing by Mountain Crest Holdings III LLC, counted once · View ↗
2,086 shares@ US$10.000.5% of flowCommon StockSEC:0001104659-21-082213:0
Canonical exit: 12 Sept 2021 (T+90)
▲
Same trade as the filing by Suying Liu, counted once · View ↗
110,000 shares@ US$10.0028.7% of flowCommon StockSEC:0001104659-21-071168:0
Canonical exit: 18 Aug 2021 (T+90)
110,000 shares@ US$10.0028.7% of flowCommon StockSEC:0001104659-21-071172:0
Canonical exit: 18 Aug 2021 (T+90)
8 of 8 declarations
About Mountain Crest Acquisition Corp. III
Mountain Crest Acquisition Corp. III is a special purpose acquisition company (SPAC), meaning it was created as a listed cash shell to pursue a merger, share exchange, asset acquisition, or similar business combination. For French-speaking investors evaluating the name MCAEU, the key point is that this is not a traditional operating company with an established product portfolio; its business model is to raise capital in the public markets and then identify and complete a transaction with a private target. Mountain Crest Acquisition Corp. III was set up within that framework, with a principal executive office historically disclosed in New York, United States, at 311 West 43rd Street, 12th Floor, New York, NY 10036. It was associated with the NASDAQ market under the MCAE/MCAEU symbols, placing it squarely in the U.S. SPAC financing ecosystem. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1859035/000182912623004491/mountaincrest5_pre14a.htm?utm_source=openai))
Historically, Mountain Crest Acquisition Corp. III belonged to a broader family of Mountain Crest-sponsored SPAC vehicles. As with most SPACs, the company was formed for a finite purpose and operated under a deadline to complete a business combination. In February 2023, it announced the closing of its merger with ETAO International Group, a digital healthcare group described as providing medical care through biomedical and AI-enabled technologies, primarily focused on patients in China. That transaction is central to the company’s investment story, because it shows that MCAEU’s role was to serve as the public-market acquisition vehicle rather than to develop a proprietary operating business. Following the transaction, the securities of the combined company were slated to trade under a different name and ticker on NASDAQ. ([nasdaq.com](https://www.nasdaq.com/press-release/mountain-crest-acquisition-corp.-iii-closes-its-business-combination-with-etao?utm_source=openai))
Read moreShow less
From a business-line standpoint, Mountain Crest Acquisition Corp. III’s “products” are really SPAC services: sourcing a target, negotiating a transaction, structuring the deal, and taking the combined company public. Its competitive position should be understood relative to other SPAC sponsors, where success depends on sponsor credibility, execution speed, capital markets access, and the ability to find a credible target within the required timeline. There is no conventional operating moat comparable to a manufacturing or software company; instead, the value proposition lies in financial structuring and deal execution. For recent developments, the most notable items are the completed business combination in 2023 and SEC filings such as Form 4 insider ownership disclosures, which are typical for issuers with active corporate-action histories. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1853775/000090266423001976/xslF345X03/ownership.xml?utm_source=openai))
In short, Mountain Crest Acquisition Corp. III should be viewed as a U.S.-listed NASDAQ SPAC from the United States, with its historical significance tied to its merger activity rather than to a standalone operating franchise.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
